Document Detail

Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
MedLine Citation:
PMID:  4007192     Owner:  NLM     Status:  MEDLINE    
Fifty-eight hyperprolactinemic women were followed up for 13 to 108 months after at least one bromocriptine-induced pregnancy for investigation of whether the pregnancy had any adverse long-term effects on the hyperprolactinemic state. Fifteen women had two term pregnancies. The prolactin (PRL) level decreased greater than 50% in 20 women after the pregnancy. Only two women showed a PRL level increase. Spontaneous uterine bleedings returned in 16 women, whereas 42 remained amenorrheic. Thus, bromocriptine-induced pregnancy in women with hyperprolactinemia has no negative long-term effect on PRL secretion.
C Rasmussen; T Bergh; S J Nillius; L Wide
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Fertility and sterility     Volume:  44     ISSN:  0015-0282     ISO Abbreviation:  Fertil. Steril.     Publication Date:  1985 Jul 
Date Detail:
Created Date:  1985-08-16     Completed Date:  1985-08-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  31-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bromocriptine / therapeutic use*
Follow-Up Studies
Infertility, Female / drug therapy*,  physiopathology
Menstruation / drug effects*
Ovulation Induction
Pituitary Neoplasms / complications,  secretion
Pregnancy Complications, Neoplastic / drug therapy,  physiopathology
Prolactin / blood,  secretion*
Reg. No./Substance:
25614-03-3/Bromocriptine; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fetal malformations following progesterone therapy during pregnancy: a preliminary report.
Next Document:  Effect of serum source on human fertilization and embryonic growth parameters in vitro.